WHO. Global tuberculosis control: surveillance, planning, financing[C]. WHO report, 2008,729.
[2]
Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing count ries:implications for new vaccines[J]. Nat Rev Immunol,2005,5(8):661-667.
[3]
Tangle A,Lefèvre P, Denis O. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors [J]. J Immunol, 1999,162(2):1113 - 1119.
[4]
Romano M,Roupie V,Hamard M. Evaluation of the immunogenicity of pBudCE4.1 plasmids encoding mycolyl-transferase Ag85A and phosphate transport receptor PstS-3 f rom Mycobacterium tuberculosis[J]. Vaccine, 2006, 24(21):4640-4643.
[5]
Andersen P. Effective vaccination of mice against Mycobacteri umtuberculosis infection with a soluble mixture of secreted mycobacterial proteins[J]. Infect Immun,1994,62(6):2536-2544.
[6]
Pal PG, Horwitz MA. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis [J]. Infect Immun,1992,60(11):4781-4792.
